EluNIR-PERL is Medinol’s most recent advancement in coronary stent technology. This seventh-generation stent features a unique stent design which utilizes a distinctive CoCr framework composed of struts with varying widths and integrates radiopaque markers into its structure.
Furthermore, the stent features a specialized radiopaque enhanced metal spring tip designed for navigating through complex anatomies. These design elements are intended to equip physicians with precise positional information, facilitating accurate stent placement during PCI procedures.
Key Features
Enhanced Deliverability and Crossability
Superior deliverability with a unique and flexible metal spring tipOutstanding Surface Integrity
Elastomeric coating and outstanding surface integrity providing a uniform rapamycin analogue drug elution
Unparalleled Visibility
Reinforced radiopaque tip and stent markers for accurate delivery and stent positioningOptimal Scaffolding and Conformability
Unique stent design providing optimal flexibility and radial strength resulting in superior scaffolding and vessel conformability
Clinical Overview
5.4%
n=958
Target Lesion Failure
1-yr BIONICS trial results
0.4%
n=958
Stent Thrombosis (Definite+Probable)
1-yr BIONICS trial results
3.2%
n=958
Target Vessel Myocardial Infraction
1-yr BIONICS trial results
Testimonials
Major Regulatory Approvals
FDA
CE Mark
